Refractive outcomes following unilateral laser treatment for type 1 retinopathy of prematurity

被引:0
|
作者
Bayramoglu, Sadik Etka [1 ,3 ]
Sayin, Nihat [1 ]
Ekinci, Dilbade Yildiz [2 ]
机构
[1] Univ Hlth Sci, Kanuni Sultan Suleyman Training & Res Hosp, Dept Ophthalmol, Istanbul, Turkey
[2] Univ Hlth Sci, Diyarbakir Training & Res Hosp, Dept Ophthalmol, Diyarbakir, Turkey
[3] Kanuni Sultan Suleyman Egitim & Aras Tirma Hastane, Goz Klin, Sadik Etka Bayramoglu, Atakent Mah Turgut Ozal Bulvari, Istanbul, Turkey
来源
JOURNAL OF AAPOS | 2022年 / 26卷 / 05期
关键词
INTRAVITREAL BEVACIZUMAB; INFANTS; MYOPIA; LESS; PHOTOCOAGULATION;
D O I
10.1016/j.jaapos.2022.07.001
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE To compare refractive outcomes of infants with type 1 retinopathy of prematurity (ROP) in whom one eye was treated with laser and the fellow eye spontaneously regressed.METHODS The medical records of infants who underwent IVB and laser treatment for type 1 ROP or aggressive posterior-ROP between January 2016 and December 2019 were retrospectively evaluated. Infants in whom ROP in the fellow eye regressed and for whom refractive data was available in the record were included in the study. Refractive outcomes of unilaterally treated infants were assessed.RESULTS A total of 283 cases were reviewed: of these, 17 experienced spontaneous regression in the fellow eye and were included. All unilateral laser-treated eyes had type 1 ROP in zone II. The median age at treatment was 40 weeks' postmenstrual age (IQR, 39-41). The mean spherical equivalent at the last examination was 2.1 +/- 2.5 D in treated eyes and 2.50 +/- 1.4 D in nontreated eyes, at a mean age of 25.0 +/- 9.1 months (P = 0.378). Of the 7 infants who underwent fluorescein angiography, the median of the ratio of the length of the temporal retinal vascularization to the optic disk-to-fovea distance was 3.71 (3.22-3.79) in treated and 4.28 (3.90-4.49) in untreated eyes, at a median age of 18 months (P = 0.018).CONCLUSIONS In laser-treated eyes with peripheral zone II ROP and with advanced treatment age, we did not observe a significant myopic change compared to the fellow untreated eye. ( J AAPOS 2022;26:245.e1-6)
引用
收藏
页码:245.e1 / 245.e6
页数:6
相关论文
共 50 条
  • [41] Influence of treatment modality on refractive outcome in retinopathy of prematurity
    Smyth, KL
    Haigh, PM
    ODonoghue, EP
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 3446 - 3446
  • [42] Long-term Visual and Refractive Outcomes of Argon Laser-treated Retinopathy of Prematurity
    Farvardin, Majid
    Kalantari, Zahra
    Talebnejad, Mohammadreza
    Alamolhoda, Marzieh
    Norouzpour, Amir
    [J]. JOURNAL OF OPHTHALMIC & VISION RESEARCH, 2022, 17 (03) : 384 - 389
  • [43] Bilateral Retinal Vascularization after Unilateral Bevacizumab for Type 1 Retinopathy of Prematurity
    Tehrani, Nasrin Najm
    Isaac, Maram
    Mireskandari, Kamiar
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [44] Refractive error outcomes after intravitreal ranibizumab for retinopathy of prematurity
    Meng, Qingyu
    Cheng, Yong
    Wu, Xi
    Zhao, Dan
    Zhao, Mingwei
    Liang, Jianhong
    [J]. CLINICAL AND EXPERIMENTAL OPTOMETRY, 2020, 103 (04) : 495 - 500
  • [45] Refractive Outcomes of Lens-Sparing Vitrectomy for Retinopathy of Prematurity
    Carvounis, Petros E.
    Poll, Jed
    Weikert, Mitch P.
    Wilhelmus, Kirk
    Lakhanpal, Rohit R.
    Holz, Eric R.
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (07) : 843 - 846
  • [46] Refractive Status of Chinese with Laser-Treated Retinopathy of Prematurity
    Ruan, Lu
    Shan, Hai-Dong
    Liu, Xing-Zong
    Huang, Xin
    [J]. OPTOMETRY AND VISION SCIENCE, 2015, 92 (04) : S3 - S9
  • [47] Neurodevelopmental Outcomes Following Intravitreal Bevacizumab With Laser Versus Laser Photocoagulation Alone for Retinopathy of Prematurity
    Ahmed, Kamran
    Ali, Anam S.
    Delwadia, Neil
    Greven, Margaret A.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2020, 51 (04): : 220 - 224
  • [48] Long-term outcomes of Type 1 Retinopathy of Prematurity (ROP) after Treatment with Bevacizumab
    Isaac, Maram
    Mireskandari, Kamiar
    Tehrani, Nasrin Najm
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [49] Long-term outcomes of type 1 retinopathy of prematurity following monotherapy with bevacizumab: a Canadian experience
    Isaac, Maram
    Mireskandari, Kamiar
    Fallaha, Nicole
    Ospina, Luis H.
    Javidi, Eileen
    Chorfi, Sarah
    Superstein, Rosanne
    Hamel, Patrick
    Tehrani, Nasrin N.
    [J]. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2023, 58 (06): : 553 - 558
  • [50] Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity
    Arima, Mitsuru
    Akiyama, Masato
    Fujiwara, Kohta
    Mori, Yujiro
    Inoue, Hirosuke
    Seki, Eiko
    Nakama, Takahito
    Tsukamoto, Shoko
    Ochiai, Masayuki
    Ohga, Shouichi
    Sonoda, Koh-Hei
    [J]. PLOS ONE, 2020, 15 (03):